When the COVID-19 pandemic upended nearly every aspect of people’s lives this year, telehealth allowed patients to continue to access health care.

Loren BonnerLoren BonnerLoren Bonner

Life moves fast. Here’s a roundup of a few of the most important policy developments to help you keep up.

Rachel Balick

The fragility of our mental health has never been more exposed than during the COVID-19 pandemic.

Loren Bonner

On July 6, a member of the Pharmacy Staff for COVID-19 Support Facebook community posed a question to their peers: “What is your prediction for this coming flu vaccination season?”

Rachel Balick

Methadone overdose has been linked to mistaken use of concentrated oral solution and scanning the wrong barcode.

Institute for Safe Medication Practices, Horsham, PA

Updates from FDA

Various researchers have noted abnormal blood clotting among patients diagnosed with COVID-19.

Charnicia Huggins, PharmD

Illegitimate online pharmacies aren’t new.

Rachel Balick

Recently, the National Center for Complementary and Integrative Health (NCCIH), a division of the National Institutes of Health, warned against the use of “alternative treatments” for COVID-19.

Aina Abell

Ear disorders affect pediatric and geriatric patients with greater frequency than other patients.

Daniel L. Krinsky, RPh, MS

Oriahnn (AbbVie) is the first and only FDA-approved oral treatment for the management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women.

Maria G. Tanzi, PharmD

Trending Topics in Health-System Pharmacy

In May, FDA approved dapagliflozin to treat patients with New York Heart Association (NYHA) class II–IV heart failure with reduced ejection fraction to reduce the risk of cardiovascular death and hospitalization.

Joey Sweeney, PharmD, BCPS

Superinfections—infections that occur alongside another infection—are often present in patients who have died from COVID-19.

Joey Sweeney, PharmD, BCPS

Over the past few months the Institute for Safe Medication Practices (ISMP) has released information on a compounding error that occurred with the investigational use of remdesivir for the management of COVID-19 patients, the potential for overdoses with a 2% propofol product recently approved by FDA for emergency use, and updated vincristine labeling and packaging.

Maria G. Tanzi, PharmD

Today’s pharmacists face both a clinical and ethical dilemma surrounding the medical use of a DEA Schedule I drug: marijuana, or specifically, one of its components, cannabidiol (CBD).

Merrill Norton, PharmD, DPh, ICCDP-D

APhA Member News

Take the Crossword Challenge

“Shirley” visited the urgent care clinic at Caring Health, a federally qualified health center (FQHC) in Springfield, MA, almost monthly for UTIs.

Sonya Collins

The standard of care in a medical malpractice lawsuit is usually established through expert witness testimony by clinicians who have extensive experience in the same specialty (or subspecialty) field as the defendant.

David B. Brushwood, BSPharm, JD